- Home
- CIA vs SLP Comparison
CIA vs SLP Comparison
Compare CIA & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIA | SLP |
|---|---|---|
| Founded | 1969 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 250.6M |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CIA | SLP |
|---|---|---|
| Price | $5.41 | $14.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 115.4K | ★ 291.7K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $255,616,000.00 | $59,577,000.00 |
| Revenue This Year | $3.10 | $2.64 |
| Revenue Next Year | $4.47 | $6.01 |
| P/E Ratio | ★ $28.23 | $51.42 |
| Revenue Growth | 4.33 | ★ 10.52 |
| 52 Week Low | $3.25 | $11.09 |
| 52 Week High | $6.40 | $36.43 |
Technical Indicators
Market Signals| Indicator | CIA | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 56.51 | 76.75 |
| Support Level | $5.10 | $14.18 |
| Resistance Level | $5.50 | $14.86 |
| Average True Range (ATR) | 0.26 | 0.83 |
| MACD | 0.09 | 0.33 |
| Stochastic Oscillator | 77.11 | 81.75 |
Price Performance
Historical ComparisonAbout CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.